HSDT
Solana Company (NASDAQ)
Financial Services — Asset Management
Solana Company operates as a listed digital asset treasury. The company enhances Solana tokens per share on the commercially viable blockchain for decentralized finance and consumer applications. It also focuses on neurological wellness. In addition, the company offers Portable Neuromodulation Stimulator, a non-implantable medical device, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. Solana Company is headquartered in Newtown, Pennsylvania.
None
2 analysts
$1.74
+$0.09 (+5.45%)
Target:
$3.50
(101.1%)
Sign in to add HSDT to a watchlist or set price alerts.
Price History
52-Week Range
Fundamentals
| Market Cap | $101.59M |
| P/E Ratio (TTM) | 0.00 |
| Forward P/E | -29.00 |
| EPS (TTM) | $379.14 |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | 7289.80% |
| ROE | -137.42% |
| Debt/Equity | - |
| Recommendation | None |
| Analyst Target | $3.50 |
| Analysts | 2 |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 64.6 |
| Beta | 1.03 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $25.50 |
| 52-Week Low | $1.19 |
| 50-Day Avg | $1.90 |
| 200-Day Avg | $4.53 |
| Avg Volume | 339.8K |
| Volume | 339.7K |
Performance Analysis
BULLISHHSDT shows predominantly bullish signals based on its fundamentals and technicals.
+
Trading near its 52-week low ($1.19), which could present a value opportunity.
+
RSI at 64.6 shows positive momentum.
-
Price is below both the 50-day and 200-day moving averages — in a downtrend.
+
P/E of 0.0 suggests the stock may be undervalued.
+
Strong revenue growth of 7289.8% year-over-year.
~
Wall Street consensus is "none" from 2 analysts.
+
Average analyst target of $3.50 implies 101.1% upside.
Recent News
Loading news...
Last updated: Jul 02, 2026 13:14 UTC
Back to Screener Export Report